Pure Biologics

Pure Biologics Current Liabilities

The Current Liabilities of Pure Biologics (PUR.WA) as of Nov 17, 2026 is 18.96 M PLN. In the previous year, Current Liabilities was 16.26 M PLN — a change of 16.57% (higher).

Current Liabilities

18.96 MPLN

YoY

16.57%

Last updated:

Current Liabilities of Pure Biologics is 2025 18.96 M PLN. Current Liabilities of Pure Biologics was 2024 16.26 M PLN. It decreases by 16.57% higher compared to the previous year.

The Pure Biologics Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2018
5.72 M PLN
Jan 1, 2019
22.00 M PLN
Jan 1, 2020
19.74 M PLN
Jan 1, 2021
10.40 M PLN
Jan 1, 2022
17.22 M PLN
Jan 1, 2023
13.20 M PLN
Jan 1, 2024
16.26 M PLN
Jan 1, 2025
18.96 M PLN
The Pure Biologics Current Liabilities history
YEARCurrent LiabilitiesYoY
18.96 MPLN+16.57%
16.26 MPLN+23.23%
13.20 MPLN-23.39%
17.22 MPLN+65.61%
10.40 MPLN-47.32%
19.74 MPLN-10.25%
22.00 MPLN+284.28%
5.72 MPLN+373.51%
1.21 MPLN+7.14%
1.13 MPLN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Pure Biologics Stock analysis

What does Pure Biologics do? Pure Biologics SA, headquartered in Wrocław, Poland, operates in the Health Care sector as a biotechnology company. It focuses on research and development of innovative biological medicines and medical devices for therapeutic and diagnostic applications. The company employs 53 full-time staff and was listed on the stock market on 11 December 2018. Founded in August 2010, it remains based in Wrocław, focusing on biopharmaceutical solutions. Pure Biologics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pure Biologics stock

Current Liabilities of Pure Biologics is 18.96 M PLN in 2025.

Current Liabilities of Pure Biologics changed from 16.26 M PLN to 18.96 M PLN, representing a 16.57% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Pure Biologics since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's PLN is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Pure Biologics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Pure Biologics

All Key Metrics — Pure Biologics